Author

Jakub Baczyński-Keller

Gdańsk University of TechnologyORCID 0000-0002-0435-9972Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anna KosteckaiD· 1 shared Arkadiusz PiotrowskiiD· 1 shared David K. CrossmaniD· 1 shared Justyna SawickaiD· 1 shared Magdalena KoczkowskaiD· 1 shared Maria DzierżyńskaiD· 1 shared Michael R. CrowleyiD· 1 shared Michał PikułaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Anna KosteckaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of a small-molecule epigenetic regenerative therapy. Subcutaneous administration of alginate formulations with high loads of zebularine and retinoic acid promotes tissue growth, vascularization and innervation and induces extensive epigenetic repatterning

Paulina Słonimska, Jakub Baczyński-Keller, Rafał Płatek, Milena Deptuła, Maria Dzierżyńska, Justyna Sawicka, Oliwia Król, Paweł Sosnowski, Magdalena Koczkowska, Anna Kostecka, David K. Crossman, Michael R. Crowley, Piotr Sass, Ryszard Tomasz Smolenski, Piotr Mariusz Skowron, , Paweł Sachadyn

This study develops alginate-based formulations of zebularine and retinoic acid for subcutaneous administration, promoting tissue regeneration and epigenetic changes in mice without adverse effects.

Scientific Reports · Oct 29, 2025Peer-reviewedBioengineering